Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Research May 21, 2019 08:00AM
Otsuka And Proteus® Announce The First U.S. FDA Approval Of A Digital Medicine System: ABILIFY MYCITE® (aripiprazole tablets with sensor) Nov 14, 2017 12:16AM
FDA Accepts Otsuka's Resubmission to Support a Regulatory Review of Tolvaptan in the Treatment of ADPKD Nov 9, 2017 07:00AM
Otsuka Announces Phase 3 Results for Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Nov 4, 2017 12:03PM
Otsuka and Lundbeck Will Initiate a Third Phase 3 Trial to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Dementia of the Alzheimer's Type Nov 1, 2017 02:00AM


Oct 27, 2017 08:00AM Otsuka to Host Web Briefing on Tolvaptan Phase 3 Trial Results in Polycystic Kidney Disease
Oct 11, 2017 05:00PM Otsuka and Lundbeck Announce Initiation of Two Phase 3 Trials of Brexpiprazole in Patients with Bipolar I Disorder
Sep 13, 2017 08:00AM Otsuka and Lundbeck to Showcase Safety and Efficacy Data in Treatments for Challenging Mental Health Conditions
Jul 28, 2017 10:38AM ABILIFY MAINTENA® (aripiprazole) for Extended-Release Injectable Suspension Approved by U.S. FDA for Maintenance Monotherapy Treatment of Bipolar I Disorder
May 23, 2017 09:00AM Otsuka and Proteus Digital Health® Resubmit Application to FDA for First Digital Medicine
May 22, 2017 08:00AM Otsuka Announces Results of Phase 3 Data on Tolvaptan
May 10, 2017 08:00AM Launch of Alzheimer’s Journey Coordinator Certificate Program™
May 2, 2017 03:00AM Otsuka and Lundbeck Announce Results of Brexpiprazole on Symptoms of Agitation Related to Alzheimer’s-Type Dementia
Mar 2, 2017 04:05PM Otsuka Pharmaceutical to Acquire Neurovance, Inc.
Jul 10, 2015 08:00PM U.S. FDA Approves Otsuka and Lundbeck’s REXULTI® (Brexpiprazole) as Adjunctive Treatment for Adults with Major Depressive Disorder and as a Treatment for Adults with Schizophrenia
Apr 17, 2015 09:00AM Results of Phase III Study of Brexpiprazole in Adult Patients with Schizophrenia Published in American Journal of Psychiatry